Clinical trial

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL…

NCT00157131 · Baxter Healthcare Corporation, Industry · Completed

Key facts

NCT number NCT00157131
Title Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
Official title A Study To Evaluate the Safety and Efficacy of Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS 4IU VH S/D) to Adhere Tissues and Improve Wound Healing
Lead sponsor Baxter Healthcare Corporation, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Deep Partial or Full Thickness Wounds
Intervention type Biological, Other
Interventions Fibrin Sealant, ARTISS 4IU/ml VH SD, Staples
Enrollment 150
Start date Jun 1, 2004
Primary completion Feb 1, 2007
Completion Feb 1, 2007
First posted Sep 12, 2005
Last update posted Apr 20, 2017
Countries United States

At a glance

  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies